Pre‐treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy

Abstract

Objective-The concept of symptom clusters is relatively new in cancer patients' symptom management. This study, which spanned four cycles of chemotherapy, combined three commonly seen pre-treatment symptoms in cancer patients (i.e., sleep disturbances, fatigue and depression) into one symptom cluster, to explore the associations between pre-treatment cluster categories and longitudinal profiles of these same symptoms during chemotherapy.Methods-This was a prospective study. Seventy-six women with newly diagnosed stage I-III breast cancer, scheduled to receive at least four cycles of adjuvant or neoadjuvant anthracyclinebased chemotherapy participated. Data were collected at seven time points before and during treatment. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI). Fatigue was measured with the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF). Depressive symptoms were measured with the Center of Epidemiological Studies-Depression (CES-D). Patients were divided into three groups based on the number of symptoms they experienced before the start of chemotherapy (i.e., no symptoms, 1-2 symptoms or all three symptoms) and a symptom cluster index (SCI) was computed.Results-All women reported worse sleep, more fatigue and more depressive symptoms during treatment compared to baseline (all p's <0.01); however, those women with a higher symptom cluster index (i.e., more symptoms pre-treatment) continued to experience worse symptoms during treatment compared to those who began with fewer symptoms (all p's <0.01).Conclusions-A higher clinically relevant-based pre-treatment symptom cluster was associated with more sleep disturbances, greater fatigue and more depressive symptoms during chemotherapy. Specific interventions for these pre-treatment symptoms may improve the frequency and severity of NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript these same symptoms during chemotherapy, when they are most severe and most disruptive to quality of life.

The Influence of Chemotherapy-Induced Neurotoxicity on Psychological Distress and Sleep Sisturbance in Cancer Patients

“…Sleep disturbances are common among patients undergoing chemotherapy 33 . Sleep deprivation might cause immunosuppression 34 , reduced functioning, greater pain, low energy, and mental health problems 35 .…”

The Evaluation of Hopelessness and Perceived Social Support Level in Patients With Lung Cancer

“…Hope determines the way an individual perceives a thread, the response to this thread, and the efficiency of this response (Oz, 2010 (Liu et al, 2009) and increased suicidal ideation (Mystakidou et al, 2009). …”

Factors influencing quality of life in patients with benign primary brain tumors: prior to and following surgery

“…Given the impact that benign brain tumor and treatmentrelated symptoms associated with this disease have for patients' QOL, studies which systematically describe QOL and explore specific issues influencing QOL over time are required [9]. In particular, there is currently limited information about the relationships between symptom distress, functional status, depression, and QOL over time, as available studies have explored the relationships among these variables using cross-sectional designs [38] or retrospective analysis [10,39] only.…”